img

Global Liposomes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Liposomes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer.
Liposomes report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liposomes market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Fungal Infection Therapy and Cancer & Tumor Therapy are the major drivers for the industry.
North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liposomes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others

Segment by Application


Fungal Infection Therapy
Cancer & Tumor Therapy
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Liposomes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Liposomes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Liposomes industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Liposomes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Liposomes introduction, etc. Liposomes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Liposomes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Liposomes Market Overview
1.1 Liposomes Product Overview
1.2 Liposomes Market Segment by Type
1.2.1 Liposomal Doxorubicin
1.2.2 Liposomal Amphoteracin B
1.2.3 Liposomal Paclitaxel
1.2.4 Others
1.3 Global Liposomes Market Size by Type
1.3.1 Global Liposomes Market Size Overview by Type (2018-2034)
1.3.2 Global Liposomes Historic Market Size Review by Type (2018-2024)
1.3.3 Global Liposomes Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Liposomes Sales Breakdown by Type (2018-2024)
1.4.2 Europe Liposomes Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Liposomes Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Liposomes Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Liposomes Sales Breakdown by Type (2018-2024)
2 Global Liposomes Market Competition by Company
2.1 Global Top Players by Liposomes Sales (2018-2024)
2.2 Global Top Players by Liposomes Revenue (2018-2024)
2.3 Global Top Players by Liposomes Price (2018-2024)
2.4 Global Top Manufacturers Liposomes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Liposomes Market Competitive Situation and Trends
2.5.1 Liposomes Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Liposomes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes as of 2022)
2.7 Date of Key Manufacturers Enter into Liposomes Market
2.8 Key Manufacturers Liposomes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Liposomes Status and Outlook by Region
3.1 Global Liposomes Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Liposomes Historic Market Size by Region
3.2.1 Global Liposomes Sales in Volume by Region (2018-2024)
3.2.2 Global Liposomes Sales in Value by Region (2018-2024)
3.2.3 Global Liposomes Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Liposomes Forecasted Market Size by Region
3.3.1 Global Liposomes Sales in Volume by Region (2024-2034)
3.3.2 Global Liposomes Sales in Value by Region (2024-2034)
3.3.3 Global Liposomes Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Liposomes by Application
4.1 Liposomes Market Segment by Application
4.1.1 Fungal Infection Therapy
4.1.2 Cancer & Tumor Therapy
4.1.3 Others
4.2 Global Liposomes Market Size by Application
4.2.1 Global Liposomes Market Size Overview by Application (2018-2034)
4.2.2 Global Liposomes Historic Market Size Review by Application (2018-2024)
4.2.3 Global Liposomes Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Liposomes Sales Breakdown by Application (2018-2024)
4.3.2 Europe Liposomes Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Liposomes Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Liposomes Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Liposomes Sales Breakdown by Application (2018-2024)
5 North America Liposomes by Country
5.1 North America Liposomes Historic Market Size by Country
5.1.1 North America Liposomes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Liposomes Sales in Volume by Country (2018-2024)
5.1.3 North America Liposomes Sales in Value by Country (2018-2024)
5.2 North America Liposomes Forecasted Market Size by Country
5.2.1 North America Liposomes Sales in Volume by Country (2024-2034)
5.2.2 North America Liposomes Sales in Value by Country (2024-2034)
6 Europe Liposomes by Country
6.1 Europe Liposomes Historic Market Size by Country
6.1.1 Europe Liposomes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Liposomes Sales in Volume by Country (2018-2024)
6.1.3 Europe Liposomes Sales in Value by Country (2018-2024)
6.2 Europe Liposomes Forecasted Market Size by Country
6.2.1 Europe Liposomes Sales in Volume by Country (2024-2034)
6.2.2 Europe Liposomes Sales in Value by Country (2024-2034)
7 Asia-Pacific Liposomes by Region
7.1 Asia-Pacific Liposomes Historic Market Size by Region
7.1.1 Asia-Pacific Liposomes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Liposomes Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Liposomes Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Liposomes Forecasted Market Size by Region
7.2.1 Asia-Pacific Liposomes Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Liposomes Sales in Value by Region (2024-2034)
8 Latin America Liposomes by Country
8.1 Latin America Liposomes Historic Market Size by Country
8.1.1 Latin America Liposomes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Liposomes Sales in Volume by Country (2018-2024)
8.1.3 Latin America Liposomes Sales in Value by Country (2018-2024)
8.2 Latin America Liposomes Forecasted Market Size by Country
8.2.1 Latin America Liposomes Sales in Volume by Country (2024-2034)
8.2.2 Latin America Liposomes Sales in Value by Country (2024-2034)
9 Middle East and Africa Liposomes by Country
9.1 Middle East and Africa Liposomes Historic Market Size by Country
9.1.1 Middle East and Africa Liposomes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Liposomes Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Liposomes Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Liposomes Forecasted Market Size by Country
9.2.1 Middle East and Africa Liposomes Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Liposomes Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Johnson & Johnson Liposomes Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Information
10.2.2 Gilead Sciences Introduction and Business Overview
10.2.3 Gilead Sciences Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Gilead Sciences Liposomes Products Offered
10.2.5 Gilead Sciences Recent Development
10.3 Pacira
10.3.1 Pacira Company Information
10.3.2 Pacira Introduction and Business Overview
10.3.3 Pacira Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pacira Liposomes Products Offered
10.3.5 Pacira Recent Development
10.4 Sun Pharmaceutical
10.4.1 Sun Pharmaceutical Company Information
10.4.2 Sun Pharmaceutical Introduction and Business Overview
10.4.3 Sun Pharmaceutical Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sun Pharmaceutical Liposomes Products Offered
10.4.5 Sun Pharmaceutical Recent Development
10.5 Luye Pharma
10.5.1 Luye Pharma Company Information
10.5.2 Luye Pharma Introduction and Business Overview
10.5.3 Luye Pharma Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Luye Pharma Liposomes Products Offered
10.5.5 Luye Pharma Recent Development
10.6 Sigma-Tau Group
10.6.1 Sigma-Tau Group Company Information
10.6.2 Sigma-Tau Group Introduction and Business Overview
10.6.3 Sigma-Tau Group Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sigma-Tau Group Liposomes Products Offered
10.6.5 Sigma-Tau Group Recent Development
10.7 Fudan-Zhangjiang
10.7.1 Fudan-Zhangjiang Company Information
10.7.2 Fudan-Zhangjiang Introduction and Business Overview
10.7.3 Fudan-Zhangjiang Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Fudan-Zhangjiang Liposomes Products Offered
10.7.5 Fudan-Zhangjiang Recent Development
10.8 Teva Pharmaceutical
10.8.1 Teva Pharmaceutical Company Information
10.8.2 Teva Pharmaceutical Introduction and Business Overview
10.8.3 Teva Pharmaceutical Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Teva Pharmaceutical Liposomes Products Offered
10.8.5 Teva Pharmaceutical Recent Development
10.9 CSPC
10.9.1 CSPC Company Information
10.9.2 CSPC Introduction and Business Overview
10.9.3 CSPC Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.9.4 CSPC Liposomes Products Offered
10.9.5 CSPC Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis Liposomes Products Offered
10.10.5 Novartis Recent Development
10.11 Kingond Pharm
10.11.1 Kingond Pharm Company Information
10.11.2 Kingond Pharm Introduction and Business Overview
10.11.3 Kingond Pharm Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Kingond Pharm Liposomes Products Offered
10.11.5 Kingond Pharm Recent Development
10.12 Spectrum Pharmaceuticals
10.12.1 Spectrum Pharmaceuticals Company Information
10.12.2 Spectrum Pharmaceuticals Introduction and Business Overview
10.12.3 Spectrum Pharmaceuticals Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Spectrum Pharmaceuticals Liposomes Products Offered
10.12.5 Spectrum Pharmaceuticals Recent Development
10.13 Shanghai New Asia
10.13.1 Shanghai New Asia Company Information
10.13.2 Shanghai New Asia Introduction and Business Overview
10.13.3 Shanghai New Asia Liposomes Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Shanghai New Asia Liposomes Products Offered
10.13.5 Shanghai New Asia Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Liposomes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Liposomes Industrial Chain Analysis
11.4 Liposomes Market Dynamics
11.4.1 Liposomes Industry Trends
11.4.2 Liposomes Market Drivers
11.4.3 Liposomes Market Challenges
11.4.4 Liposomes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Liposomes Distributors
12.3 Liposomes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Liposomal Doxorubicin
Table 2. Major Company of Liposomal Amphoteracin B
Table 3. Major Company of Liposomal Paclitaxel
Table 4. Major Company of Others
Table 5. Global Liposomes Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Liposomes Sales by Type (2018-2024) & (K Units)
Table 7. Global Liposomes Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Liposomes Sales by Type (2018-2024) & (US& Million)
Table 9. Global Liposomes Market Share in Value by Type (2018-2024)
Table 10. Global Liposomes Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Liposomes Sales by Type (2024-2034) & (K Units)
Table 12. Global Liposomes Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Liposomes Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Liposomes Sales Market Share in Value by Type (2024-2034)
Table 15. Global Liposomes Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Liposomes Sales by Type (2018-2024) & (K Units)
Table 17. North America Liposomes Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Liposomes Sales (K Units) by Type (2018-2024)
Table 19. Europe Liposomes Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Liposomes Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Liposomes Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Liposomes Sales (K Units) by Type (2018-2024)
Table 23. Latin America Liposomes Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Liposomes Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Liposomes Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Liposomes Sales by Company (2018-2024) & (K Units)
Table 27. Global Liposomes Sales Share by Company (2018-2024)
Table 28. Global Liposomes Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Liposomes Revenue Share by Company (2018-2024)
Table 30. Global Market Liposomes Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Liposomes Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Liposomes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes as of 2022)
Table 34. Date of Key Manufacturers Enter into Liposomes Market
Table 35. Key Manufacturers Liposomes Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Liposomes Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Liposomes Sales by Region (2018-2024) & (K Units)
Table 39. Global Liposomes Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Liposomes Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Liposomes Sales Market Share in Value by Region (2018-2024)
Table 42. Global Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Liposomes Sales by Region (2024-2034) & (K Units)
Table 44. Global Liposomes Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Liposomes Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Liposomes Sales Market Share in Value by Region (2024-2034)
Table 47. Global Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Liposomes Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Liposomes Sales by Application (2018-2024) & (K Units)
Table 50. Global Liposomes Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Liposomes Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Liposomes Sales Market Share in Value by Application (2018-2024)
Table 53. Global Liposomes Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Liposomes Sales by Application (2024-2034) & (K Units)
Table 55. Global Liposomes Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Liposomes Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Liposomes Sales Market Share in Value by Application (2024-2034)
Table 58. Global Liposomes Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Liposomes Sales by Application (2018-2024) (K Units)
Table 60. North America Liposomes Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Liposomes Sales by Application (2018-2024) (K Units)
Table 62. Europe Liposomes Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Liposomes Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Liposomes Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Liposomes Sales by Application (2018-2024) (K Units)
Table 66. Latin America Liposomes Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Liposomes Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Liposomes Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Liposomes Sales by Country (2018-2024) & (K Units)
Table 70. North America Liposomes Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Liposomes Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Liposomes Sales Market Share in Value by Country (2018-2024)
Table 73. North America Liposomes Sales by Country (2024-2034) & (K Units)
Table 74. North America Liposomes Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Liposomes Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Liposomes Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Liposomes Sales by Country (2018-2024) & (K Units)
Table 78. Europe Liposomes Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Liposomes Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Liposomes Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Liposomes Sales by Country (2024-2034) & (K Units)
Table 82. Europe Liposomes Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Liposomes Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Liposomes Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Liposomes Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Liposomes Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Liposomes Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Liposomes Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Liposomes Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Liposomes Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Liposomes Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Liposomes Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Liposomes Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Liposomes Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Liposomes Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Liposomes Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Liposomes Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Liposomes Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Liposomes Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Liposomes Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Liposomes Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Liposomes Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Liposomes Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Liposomes Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Liposomes Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Liposomes Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Liposomes Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Liposomes Sales Market Share in Value by Country (2024-2034)
Table 109. Johnson & Johnson Company Information
Table 110. Johnson & Johnson Introduction and Business Overview
Table 111. Johnson & Johnson Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Johnson & Johnson Liposomes Product
Table 113. Johnson & Johnson Recent Development
Table 114. Gilead Sciences Company Information
Table 115. Gilead Sciences Introduction and Business Overview
Table 116. Gilead Sciences Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Gilead Sciences Liposomes Product
Table 118. Gilead Sciences Recent Development
Table 119. Pacira Company Information
Table 120. Pacira Introduction and Business Overview
Table 121. Pacira Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Pacira Liposomes Product
Table 123. Pacira Recent Development
Table 124. Sun Pharmaceutical Company Information
Table 125. Sun Pharmaceutical Introduction and Business Overview
Table 126. Sun Pharmaceutical Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Sun Pharmaceutical Liposomes Product
Table 128. Sun Pharmaceutical Recent Development
Table 129. Luye Pharma Company Information
Table 130. Luye Pharma Introduction and Business Overview
Table 131. Luye Pharma Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Luye Pharma Liposomes Product
Table 133. Luye Pharma Recent Development
Table 134. Sigma-Tau Group Company Information
Table 135. Sigma-Tau Group Introduction and Business Overview
Table 136. Sigma-Tau Group Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Sigma-Tau Group Liposomes Product
Table 138. Sigma-Tau Group Recent Development
Table 139. Fudan-Zhangjiang Company Information
Table 140. Fudan-Zhangjiang Introduction and Business Overview
Table 141. Fudan-Zhangjiang Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Fudan-Zhangjiang Liposomes Product
Table 143. Fudan-Zhangjiang Recent Development
Table 144. Teva Pharmaceutical Company Information
Table 145. Teva Pharmaceutical Introduction and Business Overview
Table 146. Teva Pharmaceutical Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Teva Pharmaceutical Liposomes Product
Table 148. Teva Pharmaceutical Recent Development
Table 149. CSPC Company Information
Table 150. CSPC Introduction and Business Overview
Table 151. CSPC Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. CSPC Liposomes Product
Table 153. CSPC Recent Development
Table 154. Novartis Company Information
Table 155. Novartis Introduction and Business Overview
Table 156. Novartis Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Novartis Liposomes Product
Table 158. Novartis Recent Development
Table 159. Kingond Pharm Company Information
Table 160. Kingond Pharm Introduction and Business Overview
Table 161. Kingond Pharm Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Kingond Pharm Liposomes Product
Table 163. Kingond Pharm Recent Development
Table 164. Spectrum Pharmaceuticals Company Information
Table 165. Spectrum Pharmaceuticals Introduction and Business Overview
Table 166. Spectrum Pharmaceuticals Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Spectrum Pharmaceuticals Liposomes Product
Table 168. Spectrum Pharmaceuticals Recent Development
Table 169. Shanghai New Asia Company Information
Table 170. Shanghai New Asia Introduction and Business Overview
Table 171. Shanghai New Asia Liposomes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Shanghai New Asia Liposomes Product
Table 173. Shanghai New Asia Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Liposomes Market Trends
Table 177. Liposomes Market Drivers
Table 178. Liposomes Market Challenges
Table 179. Liposomes Market Restraints
Table 180. Liposomes Distributors List
Table 181. Liposomes Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Product Picture
Figure 2. Global Liposomes Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Liposomes Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Liposomes Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Liposomal Doxorubicin
Figure 6. Global Liposomal Doxorubicin Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Liposomal Amphoteracin B
Figure 8. Global Liposomal Amphoteracin B Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Liposomal Paclitaxel
Figure 10. Global Liposomal Paclitaxel Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Liposomes Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Liposomes Sales Market Share by Type in 2022 & 2034
Figure 15. North America Liposomes Sales Market Share in Volume by Type in 2022
Figure 16. North America Liposomes Sales Market Share in Value by Type in 2022
Figure 17. Europe Liposomes Sales Market Share in Volume by Type in 2022
Figure 18. Europe Liposomes Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Liposomes Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Liposomes Sales Market Share in Value by Type in 2022
Figure 21. Latin America Liposomes Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Liposomes Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Liposomes Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Liposomes Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomes Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomes Revenue in 2022
Figure 27. Liposomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Fungal Infection Therapy
Figure 29. Global Fungal Infection Therapy Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Cancer & Tumor Therapy
Figure 31. Global Cancer & Tumor Therapy Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Liposomes Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Liposomes Sales Market Share by Application in 2022 & 2034
Figure 36. North America Liposomes Sales Market Share in Volume by Application in 2022
Figure 37. North America Liposomes Sales Market Share in Value by Application in 2022
Figure 38. Europe Liposomes Sales Market Share in Volume by Application in 2022
Figure 39. Europe Liposomes Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Liposomes Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Liposomes Sales Market Share in Value by Application in 2022
Figure 42. Latin America Liposomes Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Liposomes Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Liposomes Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Liposomes Manufacturing Cost Structure
Figure 47. Liposomes Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries